Advanced Oncotherapy PLC (GB:AVO)

Advanced Oncotherapy (AVO) Financial Statements


Advanced Oncotherapy Financial Overview

Advanced Oncotherapy's market cap is currently ―. The company's EPS TTM is p; its P/E ratio is ―; Advanced Oncotherapy is scheduled to report earnings on June 26, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 2.51M£ 3.76M£ 724.70K£ 1.82M£ 5.75M
Total Assets£ 153.17M£ 141.29M£ 126.16M£ 122.29M£ 119.10M
Total Debt£ 59.74M£ 53.36M£ 58.81M£ 50.63M£ 46.16M
Net Debt£ 57.24M£ 49.59M£ 58.08M£ 48.82M£ 40.41M
Total Liabilities£ 92.65M£ 79.92M£ 89.84M£ 78.15M£ 69.52M
Stockholders Equity£ 60.52M£ 61.37M£ 36.32M£ 44.14M£ 49.58M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Advanced Oncotherapy Earnings and Revenue History

Advanced Oncotherapy Debt to Assets

Advanced Oncotherapy Cash Flow

Advanced Oncotherapy Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis